Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- More Radiologists, Radiotherapy Equipment Specialists Needed: Prof. Nakagawa
March 5, 2007
- Kowa, Kowa Pharmaceuticals to Integrate R&D, Production Functions
March 5, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 5, 2007
- PotelligentTM Technology Licensed to 8 Companies: BioWa
March 5, 2007
- SEMINAR
March 5, 2007
- Adiponectin, an Important Etiological Factor for Diabetes: Prof. Kadowaki
March 5, 2007
- TOPICS 2 articles
March 5, 2007
- R&D NEWS IN BRIEF
March 5, 2007
- MEDICAL DEVICE NEWS IN BRIEF
March 5, 2007
- 4 NME-Based Drugs, 1 New Combination Recommended for Approval
March 5, 2007
- Norvasc Most Often Prescribed as 1st-Line: EPOCA Marketing
March 5, 2007
- Avastin Recommended for Approval
March 5, 2007
- No Jobs Will Be Cut in Japan: Mr Brennan of AstraZeneca
March 5, 2007
- PMDA to Revise Its FY2004-2008 Business Plan in March
March 5, 2007
- Otsuka to Gear Up Promotion of Abilify
March 5, 2007
- REGULATORY NEWS IN BRIEF
March 5, 2007
- Mochida Joins Novartis to Promote Diovan
March 5, 2007
- Prefectures Generally Unenthusiastic about Promoting Use of Generics
March 5, 2007
- Vesicare Leads Market for Pollakisuria, Urinary Incontinence
March 5, 2007
- Ohara Pharm. Aims for Sales of \10 Bil. in FY2009
March 5, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…